Pds Biotechnology Corp (PDSB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 36,321 | 43,045 | 41,672 | 21,439 | 14,902 |
| Operating Income | -36,321 | -43,045 | -41,672 | -21,439 | -14,902 |
| Interest Expense | 4,673 | 4,206 | 1,317 | 0 | 0 |
| Other Income | 2,515 | 2,903 | 935 | 4 | 55 |
| Pre-tax Income | -38,480 | -44,348 | -42,054 | -21,435 | -14,847 |
| Income Tax | -869 | -1,406 | -1,199 | -4,517 | N/A |
| Net Income Continuous | -37,610 | -42,942 | -40,855 | -16,919 | -14,847 |
| Net Income | $-37,610 | $-42,942 | $-40,855 | $-16,919 | $-14,847 |
| EPS Basic Total Ops | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 |
| EPS Basic Continuous Ops | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 |
| EPS Diluted Total Ops | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 |
| EPS Diluted Continuous Ops | -1.03 | -1.39 | -1.43 | -0.66 | -0.89 |
| EPS Diluted Before Non-Recurring Items | -1.03 | -1.39 | -1.43 | -0.84 | -0.89 |
| EBITDA(a) | $-35,105 | $-42,336 | $-41,439 | $-21,434 | $-14,887 |